Pregnancy Discrimination Act

The Pregnancy Discrimination Act (PDA) is a federal law that prohibits employers from discriminating against employees or job applicants based on pregnancy, childbirth, or related medical conditions. The law applies to employers with 15 or more employees and covers a wide range of employment practices, including hiring, firing, promotions, and compensation.

Key features of the Pregnancy Discrimination Act include:

  • Prohibition of Discrimination: Employers are prohibited from discriminating against employees or job applicants based on pregnancy, childbirth, or related medical conditions.

  • Accommodations: Employers are required to provide reasonable accommodations to pregnant employees, such as modified work schedules, light duty assignments, or temporary transfers, as long as the accommodations do not create an undue hardship for the employer.

  • Health Insurance: Health insurance provided by an employer must cover expenses related to pregnancy and childbirth in the same way as other medical conditions.

  • Parental Leave: The PDA does not provide for specific parental leave, but it requires that employers treat pregnant employees the same as other employees who are similarly situated in their ability to work. Therefore, if an employer provides leave or other accommodations to employees who are temporarily disabled, it must also provide leave or other accommodations to pregnant employees.

The PDA is an amendment to Title VII of the Civil Rights Act of 1964 and is enforced by the Equal Employment Opportunity Commission (EEOC). Violations of the PDA can result in legal action, including back pay, compensatory and punitive damages, and injunctive relief.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.